PharmaEssentia Corporation (TPE:6446)
Taiwan · Delayed Price · Currency is TWD 509.00
+10.50 (2.11%)
Aug 5, 2025, 1:30 PM CST
Despegar.com Market Cap
PharmaEssentia has a market cap or net worth of 166.13 billion as of August 4, 2025. Its market cap has decreased by -11.75% in one year.
Market Cap
166.13B
Enterprise Value
145.08B
Revenue
11.34B
Ranking
n/a
PE Ratio
42.73
Stock Price
$509.00
Market Cap Chart
Since March 11, 2014, PharmaEssentia's market cap has increased from 39.38B to 166.13B, an increase of 321.83%. That is a compound annual growth rate of 13.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2025 | 166.47B | -18.69% |
| Dec 31, 2024 | 204.73B | 78.68% |
| Dec 29, 2023 | 114.58B | -20.34% |
| Dec 30, 2022 | 143.84B | 84.26% |
| Dec 30, 2021 | 78.07B | 215.94% |
| Dec 31, 2020 | 24.71B | 2.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 187.67B |
| Bora Pharmaceuticals Co., LTD. | 85.54B |
| Lotus Pharmaceutical | 56.54B |
| Oneness Biotech | 29.80B |
| Polaris Group | 27.62B |
| Center Laboratories | 26.60B |
| Pegavision | 23.91B |
| Sunmax Biotechnology | 22.87B |